Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Sanofi Names New CEO | Contract Pharma

What are you searching for?

Sign in
Breaking News

Sanofi Names New CEO

Paul Hudson to succeed Olivier Brandicourt as of September 1st

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanofi has appointed Paul Hudson as chief executive officer, effective September 1, to succeed Olivier Brandicourt who has decided to retire.

The Board thanked Olivier Brandicourt for the energy with which he has steered the Group through a complex period and for his decisive contribution to the company’s return to growth.

Paul Hudson most recently served as chief executive officer of Novartis Pharmaceuticals and Member of the Executive Committee of Novartis.

Mr. Hudson brings international experience, particularly in the U.S., Japan and Europe. He spent his 28-years career with major pharmaceutical companies such as Schering Plough, Astra Zeneca and Novartis. Throughout his various management positions, he has proven his strategic vision, his strong leadership and his ability to achieve the greatest challenges, particularly in terms of innovation and digital transformation. Mr. Hudson has track record in successful major product launches.

Serge Weinberg, chairman of the board of Sanofi, said, “We are very pleased that Paul Hudson has agreed to join Sanofi. His skills and experience give him all the assets he needs to accelerate growth and lead the Group’s adaptation to new strategic challenges, particularly in the areas of Research and Development and digital. His human values will enable him to mobilize all the energies and increase the agility, that a group such as Sanofi needs, to face the new challenges of our industry and the changes in healthcare systems around the world.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters